|
NWBO Northwest Biotherapeutics Inc 1072379 |
| Balance Sheet |
|
Current Assets
|
$2,574,000.00 |
|
Assets
|
$75,941,000.00 |
|
Current Liabilities
|
$73,352,000.00 |
|
Liabilities
|
$110,717,000.00 |
|
Equity
|
$-45,174,000.00 |
|
Shares Out
|
1669300000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-19,678,000.00 |
|
Investing Cash Flow
|
$-327,000.00 |
| Market Analysis |
Market Cap
|
$283,781,000.00 |
|
Price
|
$0.16 |
|
PB
|
0.51 |
|
EPS
|
-0.01 |
|
PS
|
87.91 |
|
FCF
|
$-20,005,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:34 |
|
| Apr |
May |
Jun |
|
|
2026-04-15 |
-0.04 |
2026-05-15 |
0.00 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.01 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.02 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NWBO documents filed with the SEC.
NWBO Filings
Clear
